Advances in research of radiomics and metabolomics in acute pancreatitis

Acute pancreatitis (AP) is an acute abdominal disease that is prone to organ dysfunction, with high mortality. Timely prediction of the occurrence and development trend of the disease is the prerequisite for early treatment and intervention. Radiomics can extract quantitative features from medical i...

Full description

Saved in:
Bibliographic Details
Main Author: ZHONG Jingyu, DING Defang, XING Yue, HU Yangfan, ZHANG Huan, YAO Weiwu
Format: Article
Language:zho
Published: Editorial Office of Journal of Diagnostics Concepts & Practice 2024-08-01
Series:Zhenduanxue lilun yu shijian
Subjects:
Online Access:https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1732171328599-410330296.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846161389082640384
author ZHONG Jingyu, DING Defang, XING Yue, HU Yangfan, ZHANG Huan, YAO Weiwu
author_facet ZHONG Jingyu, DING Defang, XING Yue, HU Yangfan, ZHANG Huan, YAO Weiwu
author_sort ZHONG Jingyu, DING Defang, XING Yue, HU Yangfan, ZHANG Huan, YAO Weiwu
collection DOAJ
description Acute pancreatitis (AP) is an acute abdominal disease that is prone to organ dysfunction, with high mortality. Timely prediction of the occurrence and development trend of the disease is the prerequisite for early treatment and intervention. Radiomics can extract quantitative features from medical images with high throughput and realize deep data mining. It can be used for the diagnosis of acute pancreatitis and prediction of severity, progression and recurrence of the disease. For the diagnosis of AP, CT radiomics can distinguish recurrent AP patients from functional abdominal pain, chronic pancreatitis, and recurrent AP patients, with an area under curve (AUC) of 0.88. For predicting AP recurrence, CT radiomics can accurately predict AP recurrence within 48 months, with an AUC of 0.93. For predicting the severity of AP, MRI radiomics can predict whether AP patients will progress to moderate to severe AP in the future, with an AUC of 0.85, which is better than clinical scoring systems. For predicting complications and progression of AP, MRI radiomics can effectively predict the occurrence of peripancreatic necrosis, with an AUC of 0.92. Metabolomics has confirmed that metabolic spectrum changes dynamically during the occurrence and development of AP. It has been reported that active metabolites can be used as early warning indicators for the diagnosis, etiology identification and severity assessment of AP. In addition, urinary metabolomics allows accurate diagnosis of AP, with an AUC of 0.91. For identifying the etiology of AP, the blood metabolomics models can identify patients with biliary AP, hyperlipidemic AP, and alcoholic AP, with AUCs of 0.89, 0.91, and 0.86, respectively. For predicting the severity of AP, the blood metabolomics models can accurately predict whether AP patients will progress to moderate to severe AP in the future, with an AUC of 0.99. The combination of the radiomics and metabolomics can complement each other's advantages and integrate multi-group data, which can jointly characterize the process and internal connections of disease occurrence and development from different levels, for achieving early warning and early intervention more effectively.
format Article
id doaj-art-ff9abaebbea74a1eb9660e5705a00651
institution Kabale University
issn 1671-2870
language zho
publishDate 2024-08-01
publisher Editorial Office of Journal of Diagnostics Concepts & Practice
record_format Article
series Zhenduanxue lilun yu shijian
spelling doaj-art-ff9abaebbea74a1eb9660e5705a006512024-11-21T09:06:48ZzhoEditorial Office of Journal of Diagnostics Concepts & PracticeZhenduanxue lilun yu shijian1671-28702024-08-01230444545110.16150/j.1671-2870.2024.04.014Advances in research of radiomics and metabolomics in acute pancreatitisZHONG Jingyu, DING Defang, XING Yue, HU Yangfan, ZHANG Huan, YAO Weiwu01. Department of Imaging, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China;2. Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaAcute pancreatitis (AP) is an acute abdominal disease that is prone to organ dysfunction, with high mortality. Timely prediction of the occurrence and development trend of the disease is the prerequisite for early treatment and intervention. Radiomics can extract quantitative features from medical images with high throughput and realize deep data mining. It can be used for the diagnosis of acute pancreatitis and prediction of severity, progression and recurrence of the disease. For the diagnosis of AP, CT radiomics can distinguish recurrent AP patients from functional abdominal pain, chronic pancreatitis, and recurrent AP patients, with an area under curve (AUC) of 0.88. For predicting AP recurrence, CT radiomics can accurately predict AP recurrence within 48 months, with an AUC of 0.93. For predicting the severity of AP, MRI radiomics can predict whether AP patients will progress to moderate to severe AP in the future, with an AUC of 0.85, which is better than clinical scoring systems. For predicting complications and progression of AP, MRI radiomics can effectively predict the occurrence of peripancreatic necrosis, with an AUC of 0.92. Metabolomics has confirmed that metabolic spectrum changes dynamically during the occurrence and development of AP. It has been reported that active metabolites can be used as early warning indicators for the diagnosis, etiology identification and severity assessment of AP. In addition, urinary metabolomics allows accurate diagnosis of AP, with an AUC of 0.91. For identifying the etiology of AP, the blood metabolomics models can identify patients with biliary AP, hyperlipidemic AP, and alcoholic AP, with AUCs of 0.89, 0.91, and 0.86, respectively. For predicting the severity of AP, the blood metabolomics models can accurately predict whether AP patients will progress to moderate to severe AP in the future, with an AUC of 0.99. The combination of the radiomics and metabolomics can complement each other's advantages and integrate multi-group data, which can jointly characterize the process and internal connections of disease occurrence and development from different levels, for achieving early warning and early intervention more effectively.https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1732171328599-410330296.pdf|radiomics|metabolomics|acute pancreatitis
spellingShingle ZHONG Jingyu, DING Defang, XING Yue, HU Yangfan, ZHANG Huan, YAO Weiwu
Advances in research of radiomics and metabolomics in acute pancreatitis
Zhenduanxue lilun yu shijian
|radiomics|metabolomics|acute pancreatitis
title Advances in research of radiomics and metabolomics in acute pancreatitis
title_full Advances in research of radiomics and metabolomics in acute pancreatitis
title_fullStr Advances in research of radiomics and metabolomics in acute pancreatitis
title_full_unstemmed Advances in research of radiomics and metabolomics in acute pancreatitis
title_short Advances in research of radiomics and metabolomics in acute pancreatitis
title_sort advances in research of radiomics and metabolomics in acute pancreatitis
topic |radiomics|metabolomics|acute pancreatitis
url https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1732171328599-410330296.pdf
work_keys_str_mv AT zhongjingyudingdefangxingyuehuyangfanzhanghuanyaoweiwu advancesinresearchofradiomicsandmetabolomicsinacutepancreatitis